RS1501908 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:LDL cholesterol]"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Triglyceride levels | G | β: 0.052 | 9E-40 | PubMed |
| Medication use for hyperlipidemia (number of purchases) | — | β: 0.016 | 1E-34 | PubMed |
| Total cholesterol levels | G | β: 0.049 | 2E-29 | PubMed |
| Triglycerides | G | β: 0.04 | 1E-23 | PubMed |
| Polyunsaturated fatty acids to monounsaturated fatty acids ratio | C | β: 0.02 | 8E-22 | PubMed |
| Low density lipoprotein cholesterol levels | G | β: 0.042 | 5E-21 | PubMed |
| Mean reticulocyte volume | C | β: 0.022 | 7E-21 | PubMed |
| Triglyceride to phosphoglyceride ratio | G | β: 0.028 | 8E-20 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | C | β: 0.044 | 7E-17 | PubMed |
| Saturated fatty acids levels | G | — | 6E-16 | PubMed |
| Omega-3 fatty acid levels | G | — | 7E-15 | PubMed |
| Cholesterol to Total Lipids in Medium HDL percentage | C | β: 0.02 | 1E-14 | PubMed |
| Hypercholesterolemia | C | OR: 0.9 | 6E-13 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | G | β: 0.041 | 2E-12 | PubMed |
| Lymphocyte count | C | — | 5E-12 | PubMed |
| Anterior gradient protein 3 levels | C | β: 0.093 | 7E-12 | PubMed |
| LDL cholesterol | G | β: 0.07 | 1E-11 | PubMed |
| Phospholipids to Total Lipids in Medium HDL percentage | C | β: 0.01 | 3E-11 | PubMed |
| Omega-3 fatty acid levels | G | — | 6E-11 | PubMed |
| Total cholesterol levels | — | OR: 2.39 | 3E-10 | PubMed |